D.H.E. 45 Dosage
Generic name: Dihydroergotamine Mesylate 1mg in 1mL
Dosage form: injection, solution
Drug class: Antimigraine agents
Medically reviewed by Drugs.com. Last updated on Mar 24, 2025.
D.H.E. 45 (dihydroergotamine mesylate) Injection, USP should be administered in a dose of 1 mL intravenously, intramuscularly or subcutaneously. The dose can be repeated, as needed, at 1-hour intervals to a total dose of 3 mL for intramuscular or subcutaneous delivery or 2 mL for intravenous delivery in a 24-hour period. The total weekly dosage should not exceed 6 mL. D.H.E. 45 (dihydroergotamine mesylate) Injection, USP should not be used for chronic daily administration.
Frequently asked questions
More about D.H.E. 45 (dihydroergotamine)
- Check interactions
- Compare alternatives
- Reviews (10)
- Side effects
- During pregnancy
- Generic availability
- Drug class: antimigraine agents
- Breastfeeding
Patient resources
Other brands
Trudhesa, Atzumi, Migranal, Brekiya
Professional resources
Other brands
Trudhesa, Atzumi, Migranal, Brekiya
Related treatment guides
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
